Eversense XL CGM System
Up to 180-Days of Sensor Life
Other CGM systems require a sensor removal and reinsertion every 2 weeks or more, while the Eversense XL Sensor lasts up to 180 days.
Smart Transmitter
Eversense XL offers you the flexibility and discretion to remove the transmitter without wasting a sensor.
iOS and Android App
With Eversense XL, you can see your readings directly on your compatible mobile device. And with readings every 5 minutes, you can see where you are now and where you’re headed with the trend arrows.3
Eversense XL CGM System
Eversense XL is the first and only long-term CGM that has a sensor that lasts up to 180 days and is changed by your health care provider - no more weekly self-insertions. Eversense provides you with the freedom you've always wanted in a CGM.
-
288 readings every 24 hours
Glucose readings and trend arrows every 5 minutes help show not only where you are, but where you're going, and can help you manage your diabetes before going too high or too low.Gentle, non-irritating adhesive
Eversense uses a gentle silicone-based adhesive that’s gentle on the skin.Alerts you can see, feel and hear
Eversense XL can send you pop-up messages on your phone, sound an alert or vibrate on your arm to alert you to highs and lows, based on your customized settings.No Sensor Self-Insertion
Eversense XL is inserted by your health care provider and lasts up to 180 days, letting you avoid the burdensome self-insertion process every 7-14 days.
1 Kropff, J., Choudhary, P., Neupane, S., Barnard, K., Bain, S. C., Kapitza, C., ... & DeVries, J. H. (2017). Accuracy and longevity of an implantable continuous glucose sensor in the PRECISE study: a 180-day, prospective, multicenter, pivotal trial. Diabetes Care, 40(1), 63-68.
2 Christiansen, M. P., Klaff, L. J., Brazg, R., Chang, A. R., Levy, C. J., Lam, D., ... & Kelley, L. (2018). A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II. Diabetes Technology & Therapeutics. (PRECISE II).7. Glycemic Targets: Standards of Medical Care in Diabetes-2018 Diabetes Care 2018;41(Suppl. 1):S55–S64
3 Data on file.
